These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17542277)

  • 1. [Frequency of NAFLD in a group of patients with metabolic syndrome in Veracruz, Mexico].
    Roesch-Dietlen F; Dorantes-Cuéllar A; Carrillo-Toledo MG; Martínez-Sibaja C; Rojas-Carrera S; Bonilla-Rojas QC; Uchino-Higueras V; Lagunas T; Carrasco-Arróniz MA; Soler-Leal B; León-Valdivieso J; Cid-Juárez S; Martínez JA
    Rev Gastroenterol Mex; 2006; 71(4):446-52. PubMed ID: 17542277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Frequency and clinical, biochemical and histological characteristics of nonalcoholic fatty liver disease in patients with gallstone disease].
    Roesch-Dietlen F; Pérez-Morales A; Melo-Santisteban G; Díaz-Blanco F; Martínez-Fernández S; Martínez JA; Cid-Juárez S
    Cir Cir; 2008; 76(1):37-42. PubMed ID: 18492418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound evaluation and correlates of fatty liver disease: a population study in a Mediterranean area.
    Chiloiro M; Caruso MG; Cisternino AM; Inguaggiato R; Reddavide R; Bonfiglio C; Guerra V; Notarnicola M; De Michele G; Correale M; Noviello MR; Misciagna G
    Metab Syndr Relat Disord; 2013 Oct; 11(5):349-58. PubMed ID: 23758075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined influence of nonalcoholic fatty liver and body size phenotypes on diabetes risk.
    Du T; Yu X; Yuan G; Zhang J; Sun X
    Cardiovasc Diabetol; 2015 Oct; 14():144. PubMed ID: 26511621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
    Portillo-Sanchez P; Bril F; Maximos M; Lomonaco R; Biernacki D; Orsak B; Subbarayan S; Webb A; Hecht J; Cusi K
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2231-8. PubMed ID: 25885947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abdominal ultrasound for diagnosis of nonalcoholic fatty liver disease (NAFLD).
    Mishra P; Younossi ZM
    Am J Gastroenterol; 2007 Dec; 102(12):2716-7. PubMed ID: 18042105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis].
    Choi SY; Kim D; Kang JH; Park MJ; Kim YS; Lim SH; Kim CH; Lee HS
    Korean J Hepatol; 2008 Mar; 14(1):77-88. PubMed ID: 18367860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit?
    Almobarak AO; Barakat S; Suliman EA; Elmadhoun WM; Mohamed NA; Abobaker IO; Noor SK; Bushara SO; Ahmed MH
    Arab J Gastroenterol; 2015 Jun; 16(2):54-8. PubMed ID: 26174761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults.
    Sinn DH; Gwak GY; Park HN; Kim JE; Min YW; Kim KM; Kim YJ; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Am J Gastroenterol; 2012 Apr; 107(4):561-7. PubMed ID: 22108448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The severity of histologic liver lesions is independent of body mass index in patients with nonalcoholic fatty liver disease.
    Margariti A; Deutsch M; Manolakopoulos S; Tiniakos D; Papatheodoridis GV
    J Clin Gastroenterol; 2013 Mar; 47(3):280-6. PubMed ID: 23391869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which metabolic syndrome criteria best predict the presence of non-alcoholic fatty liver disease?
    Seo HI; Cho YK; Lee WY; Rhee EJ; Sung KC; Kim BS; Son BH; Shin JH; Joo KJ; Hong HP; Chae SW; Jin W
    Diabetes Res Clin Pract; 2012 Jan; 95(1):19-24. PubMed ID: 21908065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.
    Akyuz U; Yesil A; Yilmaz Y
    Scand J Gastroenterol; 2015 Mar; 50(3):341-6. PubMed ID: 25540973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty liver and the metabolic syndrome among Shanghai adults.
    Fan JG; Zhu J; Li XJ; Chen L; Lu YS; Li L; Dai F; Li F; Chen SY
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1825-32. PubMed ID: 16336439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic fatty liver disease in severely obese subjects.
    Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
    Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.
    Chakrabarty M; Jha AN; Sharma DJ
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults.
    Kim HJ; Kim HJ; Lee KE; Kim DJ; Kim SK; Ahn CW; Lim SK; Kim KR; Lee HC; Huh KB; Cha BS
    Arch Intern Med; 2004 Oct; 164(19):2169-75. PubMed ID: 15505132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of NAFLD and metabolic syndrome in asymtomatics subjects].
    Lizardi-Cervera J; Laparra DI; Chávez-Tapia NC; Ostos ME; Esquivel MU
    Rev Gastroenterol Mex; 2006; 71(4):453-9. PubMed ID: 17542278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not.
    Younossi ZM; Otgonsuren M; Venkatesan C; Mishra A
    Metabolism; 2013 Mar; 62(3):352-60. PubMed ID: 22999011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT).
    Kalra S; Vithalani M; Gulati G; Kulkarni CM; Kadam Y; Pallivathukkal J; Das B; Sahay R; Modi KD
    J Assoc Physicians India; 2013 Jul; 61(7):448-53. PubMed ID: 24772746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic fatty liver disease (NAFLD)--the hepatic component of metabolic syndrome.
    Uchil D; Pipalia D; Chawla M; Patel R; Maniar S; Narayani ; Juneja A
    J Assoc Physicians India; 2009 Mar; 57():201-4. PubMed ID: 19588647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.